Catherine Wentowski is a Respiratory physician. OpenAlex indexes 20 publications with 800 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Robert Wood Johnson Pl
New Brunswick, NJ 089011928
Telephone
732-828-3000Provider last certified this registry record 4 Feb 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20247 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
- GENZYME CORPORATIONProgram year20236 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
90.4%Corticosteroid54.1%Trelegy Ellipta59%Breztri Aerosphere19%Breo Ellipta13%Fluticasone Propionate9%Part D<11 patientsbeta2-Adrenergic Agonist18.7%Albuterol Sulfate Hfa100%Part D≥28 patients+ 3 more classes in this area
Dermatology
5%Interleukin-4 Receptor alpha Antagonist5%Dupixent Pen100%Part D<11 patientsMetabolism & gastrointestinal
4.6%Corticosteroid4.6%Prednisone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacology and clinical use of plasma expanders: a 2026 update
Anaesthesia & intensive care medicine
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”